GSK
Geraldine Low

Lead Product Research & Designer, Artificial Intelligence and Machine Learning at GSK

  Greater London, England, United Kingdom

About me

Schedule

My Session

Panel Discussion: What Will Separate the Winners in Technology-Enabled Drug Discovery?

As new technologies become widely accessible, competitive advantage will increasingly depend on how organisations combine science, proprietary data, talent and technology. Senior leaders discuss what will differentiate tomorrow's most successful discovery organisations.

  • Where technology is creating genuine scientific advantage.
  • Proprietary data versus increasingly accessible models and platforms.
  • Building differentiated discovery capabilities.
  • Combining internal expertise with external innovation ecosystems.
  • Where pharmaceutical R&D leaders should invest next.

Drug Discovery and Development
Leadership and Strategy

Geraldine Low

Lead Product Research & Designer, Artificial Intelligence and Machine Learning at GSK